PET in coma and in vegetative state

Area of Science:

• Neuroscience
• Medical Imaging
• Critical Care Medicine

Background:

• Advances in critical care allow survival of patients with severe brain damage, often resulting in coma or vegetative states.
• Assessing the extent of structural brain damage and predicting recovery of conscious function is challenging using traditional methods.
• Positron emission tomography (PET) offers advanced insights into brain metabolism and neuronal integrity.

Purpose of the Study:

• To investigate the utility of 18F-fluordeoxyglucose (FDG) and 11C-flumazenil (FMZ) PET scans in evaluating brain function and structure in patients with severe brain damage.
• To compare metabolic and neuronal integrity assessments in acute vegetative state (AVS) and other disorders of consciousness.
• To explore the potential of functional activation studies in detecting residual cortical function.

Main Methods:

• Utilized 18F-fluordeoxyglucose (FDG)-PET to measure overall glucose utilization in the brain.
• Employed 11C-flumazenil (FMZ)-PET to assess benzodiazepine receptor (BZR) density as an indicator of neuronal integrity.
• Investigated brain activation using H215O-PET in response to auditory stimuli in patients with minimally conscious states.

Main Results:

• Significantly reduced glucose utilization was observed in patients with acute vegetative state (AVS) compared to controls.
• FMZ-PET revealed reduced BZR density in cortical areas, while the cerebellum appeared spared, indicating structural neuronal loss.
• FDG- and FMZ-PET findings in AVS suggest that reduced glucose metabolism reflects irreversible structural damage, not just functional inactivation.
• Auditory stimuli with emotional valence induced greater brain activation than meaningless noise in some minimally conscious patients, indicating residual function.

Conclusions:

• FDG- and FMZ-PET are valuable tools for assessing both metabolic and structural brain damage in patients with disorders of consciousness.
• These PET techniques can help differentiate between functional impairment and irreversible neuronal loss, crucial for prognostication.
• Combining functional activation studies with neuronal damage assessment may offer an optimal strategy for predicting recovery in comatose patients.